What is Procysbi, and how is it used?
Procysbi (mercaptopropionylglycine) is a prescription medicine used for the long-term treatment of people with cystinuria, a genetic condition that causes cystine stones to form in the urinary tract. Horizon Therapeutics markets Procysbi. [1]
Is Procysbi made or sold by Horizon Therapeutics?
Horizon Therapeutics is associated with the commercial side of Procysbi (marketing/sales). [1]
What disease does cystinuria involve, and why does Procysbi matter?
Cystinuria leads to cystine stones in urine. Procysbi helps manage the condition by changing how cystine behaves in the body, aiming to reduce the risk of stone formation. [1]
What happens if someone stops Procysbi?
Stopping long-term therapy can increase the risk that cystine stones will form again, because the treatment is intended to be ongoing for cystinuria. [1]
Where can I find dosing, safety, and prescribing details?
For Procysbi, Horizon (via the product’s prescribing information or official product materials) is the primary source for dosing instructions and safety information. [1]
What other Horizon products are related to rare diseases?
Horizon Therapeutics focuses on specialty and rare disease medicines, but the specific “horizon therapeutics” relationship depends on the product you mean. If you share the exact product name or what you’re comparing, I can narrow it to the right therapy and indication.
Sources:
[1] https://www.horizontherapeutics.com/medicines/procysbi